Robak Tadeusz, Kasprzak Jarosław D, Jesionek-Kupnicka Dorota, Chudobiński Cezary, Robak Paweł
Department of Hematology, Medical University of Lodz, 93-510 Lodz, Poland.
Department of General Hematology, Copernicus Memorial Hospital, 93-510 Lodz, Poland.
J Clin Med. 2022 Nov 26;11(23):6983. doi: 10.3390/jcm11236983.
Cardiac involvement of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is recognized extremely rarely. In addition, most CLL/SLL patients with heart infiltration are asymptomatic. In this review, we present the results of a literature search for English language articles concerning CLL/SLL or Richter transformation with symptomatic cardiac involvement. In total, 18 well-described cases with CLL/SLL and heart infiltration were identified. Only three patients were not diagnosed with CLL/SLL before the cardiac manifestation. In other patients, cardiac CLL/SLL was diagnosed between 5 months and 20 years from CLL/SLL diagnosis. All patients in these series had a diagnosis of secondary cardiac CLL/SLL. In addition, we identified four reported cases with Richter transformation in the heart. The treatment of patients with CLL/SLL and cardiac infiltration is variable and depends on the previous history and clinical characteristics of heart infiltration. In addition, no recommendations exist on how to treat patients with CLL/SLL and cardiac involvement.
慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(CLL/SLL)累及心脏极为罕见。此外,大多数心脏浸润的CLL/SLL患者并无症状。在本综述中,我们展示了一项文献检索的结果,该检索针对有关伴有症状性心脏受累的CLL/SLL或Richter转化的英文文章。总共确定了18例描述详尽的CLL/SLL合并心脏浸润病例。仅有3例患者在出现心脏表现之前未被诊断为CLL/SLL。在其他患者中,心脏CLL/SLL在CLL/SLL诊断后的5个月至20年之间被确诊。这些系列中的所有患者均被诊断为继发性心脏CLL/SLL。此外,我们还确定了4例心脏发生Richter转化的报告病例。CLL/SLL合并心脏浸润患者的治疗方式各不相同,取决于既往病史和心脏浸润的临床特征。此外,对于如何治疗CLL/SLL合并心脏受累的患者尚无相关建议。